Blog

According to the report by Expert Market Research (EMR), the global atherectomy devices market size attained a value of USD 767.2 million in 2023. Aided by the increasing prevalence of peripheral and coronary artery diseases and the expanding use of atherectomy devices in interventional cardiology, the market is anticipated to grow at a CAGR of 10.38% during the forecast period of 2024-2032 to attain a value of USD 1864.9 million by 2032.

Atherectomy devices are specialised catheters employed for the treatment of blocked arteries, primarily caused by peripheral artery disease (PAD) and coronary artery disease (CAD). These devices are typically used to clear plaque within the blood vessels, thus restoring appropriate blood flow and minimising the risk of heart attack or stroke. Besides their core function of plaque removal, atherectomy devices also offer excellent flexibility and cross ability, making them a valuable tool in various medical applications, including coronary interventions and peripheral vascular interventions.

Get a Free Sample Report with Table of Contents- https://www.expertmarketresearch.com/reports/atherectomy-devices-market/requestsample

The increasing global prevalence of peripheral and coronary artery diseases is driving the atherectomy devices market growth. With the rising awareness about cardiovascular diseases and their associated risks, there has been a significant shift towards advanced treatment modalities, leading to a surge in demand for atherectomy devices. Additionally, the rising geriatric population, which is more prone to cardiovascular conditions, has further contributed to the increasing adoption of atherectomy devices, given their effectiveness in treating vascular occlusions.

The expanding applications of atherectomy devices in various areas of medical practice are also instrumental in propelling the atherectomy devices market development. In interventional cardiology, atherectomy devices are used to effectively treat calcified coronary lesions that are often challenging to manage with standard balloon angioplasty. The capacity to modify plaque composition and create a more compliant lesion site makes atherectomy devices crucial in coronary interventions.

Furthermore, the growing emphasis on minimally invasive procedures in the medical field has led to a heightened focus on atherectomy devices, increasing the atherectomy devices market demand. Minimally invasive techniques offer advantages such as reduced patient trauma, quicker recovery times, and lower complication rates, aligning with the ongoing trend towards patient-centric care. With the rise of technology and the increasing popularity of advanced therapeutic procedures, atherectomy devices have emerged as an essential component in the management of cardiovascular diseases, thereby fuelling the atherectomy devices market expansion.

Read Full Report with Table of Contents- https://www.expertmarketresearch.com/reports/atherectomy-devices-market

Atherectomy Devices Market Segmentation                               

The market can be divided based on type, application, end user, and region.

Market Breakup by Type

• Directional Atherectomy Systems
• Orbital Atherectomy Systems
• Photo-ablative (Laser) Atherectomy Systems
• Rotational Atherectomy Systems

Market Breakup by Application

• Peripheral Vascular Applications
• Cardiovascular Applications
• Neurovascular Applications

Market Breakup by End User

• Hospitals and Surgical Centres
• Ambulatory Care Centres
• Other End Users

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global atherectomy devices companies. Some of the major key players explored in the report by Expert Market Research are as follows:

• Abbott Laboratories
• Boston Scientific Corporation
• BD
• Cardinal Health Inc.
• Koninklijke Philips NV
• Medtronic Plc
• Terumo Corporation
• Avinger
• Cardiovascular Systems
• Ra Medical Systems

and mergers and acquisitions, among other latest developments of these market players.